Lupin informs about disclosure

08 Jul 2020 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that the Company has voluntarily recalling its Metformin Hydrochloride Extended- Release Tablets USP, 500mg and 1000mg products in the US. This recall is being conducted out of an abundance of caution in line with the ongoing interaction with the US Food and Drug Administration on NDMA impurity levels. The associated press release in the US is enclosed for reference.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

1617.85 19.65 (1.23%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.